J1330 — Injection, ergonovine maleate, up to 0.2 mg
J1330 is a HCPCS Level II code for injection, ergonovine maleate, up to 0.2 mg. It belongs to the Drugs Administered Other Than Oral Method section. It was terminated on December 31, 2025 and is not valid on new claims.
This code has been terminated
CMS terminated J1330 on December 31, 2025. It stays in the file as history — a claim you are auditing from before that date may legitimately carry it — but it must not appear on a new claim. The adjacent codes below are the usual place to look for its replacement.
Medicare coverage: Special coverage instructions apply
There are published conditions attached to this code. Check the applicable coverage policy before billing it: the code being valid is not the same as the service being covered.
From the coverage field of the CMS Alpha-Numeric HCPCS File, release 2026Q3-Jul. This states Medicare’s position on the code, not on your particular claim.
The CMS record for J1330
- Long descriptor
- Injection, ergonovine maleate, up to 0.2 mg
- Short descriptor
- Ergonovine maleate injection
- Added
- January 1, 1986
- Terminated
- December 31, 2025
- BETOS
- O1E
- Pricing indicator
- 51 — Other
The official wording. This is what the code means.
CMS's 28-character form, which is what shows up on a remittance advice.
When CMS introduced the code.
When CMS retired it.
Berenson-Eggers Type of Service — CMS's own analytic grouping.
Drugs.
Codes adjacent to J1330
HCPCS has no hierarchy — related items simply sit next to each other in the numbering. If J1330 is not quite right, the correct code is very often within a few positions of it.
- J1308Injection, famotidine, 0.25 mg
- J1320Injection, amitriptyline hcl, up to 20 mg
- J1322Injection, elosulfase alfa, 1 mg
- J1323Injection, elranatamab-bcmm, 1 mg
- J1324Injection, enfuvirtide, 1 mg
- J1325Injection, epoprostenol, 0.5 mg
- J1326Injection, zolbetuximab-clzb, 2 mg
- J1327Injection, eptifibatide, 5 mg
- J1335Injection, ertapenem sodium, 500 mg
- J1364Injection, erythromycin lactobionate, per 500 mg
- J1370Injection, esomeprazole sodium, 1 mg
- J1380Injection, estradiol valerate, up to 10 mg
- J1410Injection, estrogen conjugated, per 25 mg
- J1411Injection, etranacogene dezaparvovec-drlb, per therapeutic dose
- J1412Injection, valoctocogene roxaparvovec-rvox, per ml, containing nominal 2 x 10^13 vector genomes
- J1413Injection, delandistrogene moxeparvovec-rokl, per therapeutic dose
Questions about J1330
What is HCPCS code J1330?
J1330 is a HCPCS Level II code for injection, ergonovine maleate, up to 0.2 mg. It sits in the Drugs Administered Other Than Oral Method section.
Does Medicare cover J1330?
The CMS HCPCS file marks J1330 as "Special coverage instructions apply". There are published conditions attached to this code. Check the applicable coverage policy before billing it: the code being valid is not the same as the service being covered.
Is J1330 still valid?
No. J1330 was terminated on December 31, 2025 and should not be used on new claims.